SARTORIUS AG (SRT.DE) Stock Fundamental Analysis
FRA:SRT - DE0007165607 - Common Stock
158.8 EUR
-5 (-3.05%)
SRT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 18 industry peers in the Life Sciences Tools & Services industry. SRT has a bad profitability rating. Also its financial health evaluation is rather negative. SRT is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT was profitable.
SRT had a positive operating cash flow in the past year.
SRT had positive earnings in each of the past 5 years.
SRT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.04%, SRT is doing worse than 77.78% of the companies in the same industry.
With a Return On Equity value of 3.92%, SRT is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 3.80%, SRT is doing worse than 66.67% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SRT is in line with the industry average of 7.14%.
The 3 year average ROIC (8.34%) for SRT is well above the current ROIC(3.80%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.04% | ||
| ROE | 3.92% | ||
| ROIC | 3.8% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
The Profit Margin of SRT (3.00%) is worse than 72.22% of its industry peers.
In the last couple of years the Profit Margin of SRT has declined.
With a Operating Margin value of 12.48%, SRT is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of SRT has declined.
With a decent Gross Margin value of 45.76%, SRT is doing good in the industry, outperforming 77.78% of the companies in the same industry.
In the last couple of years the Gross Margin of SRT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.48% | ||
| PM (TTM) | 3% | ||
| GM | 45.76% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SRT is creating some value.
The number of shares outstanding for SRT has been increased compared to 1 year ago.
Compared to 5 years ago, SRT has more shares outstanding
Compared to 1 year ago, SRT has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 1.90 indicates that SRT is not a great score, but indicates only limited risk for bankruptcy at the moment.
SRT's Altman-Z score of 1.90 is on the low side compared to the rest of the industry. SRT is outperformed by 66.67% of its industry peers.
SRT has a debt to FCF ratio of 8.09. This is a slightly negative value and a sign of low solvency as SRT would need 8.09 years to pay back of all of its debts.
SRT has a worse Debt to FCF ratio (8.09) than 61.11% of its industry peers.
A Debt/Equity ratio of 1.54 is on the high side and indicates that SRT has dependencies on debt financing.
SRT has a worse Debt to Equity ratio (1.54) than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | 8.09 | ||
| Altman-Z | 1.9 |
ROIC/WACC0.52
WACC7.32%
2.3 Liquidity
SRT has a Current Ratio of 1.39. This is a normal value and indicates that SRT is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.39, SRT is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
A Quick Ratio of 0.88 indicates that SRT may have some problems paying its short term obligations.
SRT has a worse Quick ratio (0.88) than 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 0.88 |
3. Growth
3.1 Past
SRT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.21%, which is quite impressive.
The earnings per share for SRT have been decreasing by -11.87% on average. This is quite bad
The Revenue has been growing slightly by 3.80% in the past year.
Measured over the past years, SRT shows a quite strong growth in Revenue. The Revenue has been growing by 13.10% on average per year.
EPS 1Y (TTM)33.21%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%7.02%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%2.74%
3.2 Future
SRT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.58% yearly.
The Revenue is expected to grow by 8.96% on average over the next years. This is quite good.
EPS Next Y22.55%
EPS Next 2Y20.62%
EPS Next 3Y22.38%
EPS Next 5Y19.58%
Revenue Next Year5.4%
Revenue Next 2Y7.24%
Revenue Next 3Y8.62%
Revenue Next 5Y8.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 36.51, which means the current valuation is very expensive for SRT.
SRT's Price/Earnings ratio is a bit more expensive when compared to the industry. SRT is more expensive than 66.67% of the companies in the same industry.
SRT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.44.
The Price/Forward Earnings ratio is 26.63, which means the current valuation is very expensive for SRT.
SRT's Price/Forward Earnings is on the same level as the industry average.
SRT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.51 | ||
| Fwd PE | 26.63 |
4.2 Price Multiples
SRT's Enterprise Value to EBITDA ratio is in line with the industry average.
SRT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SRT is cheaper than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.67 | ||
| EV/EBITDA | 18.73 |
4.3 Compensation for Growth
SRT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
SRT's earnings are expected to grow with 22.38% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.62
PEG (5Y)N/A
EPS Next 2Y20.62%
EPS Next 3Y22.38%
5. Dividend
5.1 Amount
With a yearly dividend of 0.47%, SRT is not a good candidate for dividend investing.
SRT's Dividend Yield is comparable with the industry average which is at 0.73.
With a Dividend Yield of 0.47, SRT pays less dividend than the S&P500 average, which is at 2.45.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.47% |
5.2 History
The dividend of SRT has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
48.70% of the earnings are spent on dividend by SRT. This is a bit on the high side, but may be sustainable.
The dividend of SRT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP48.7%
EPS Next 2Y20.62%
EPS Next 3Y22.38%
FRA:SRT (9/11/2025, 7:00:00 PM)
158.8
-5 (-3.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.37%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.89B
Analysts77.14
Price Target272.34 (71.5%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.47% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP48.7%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.33%
Min EPS beat(2)-10.52%
Max EPS beat(2)-4.13%
EPS beat(4)0
Avg EPS beat(4)-10.28%
Min EPS beat(4)-22.4%
Max EPS beat(4)-4.06%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.97%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)2.67%
Revenue beat(4)2
Avg Revenue beat(4)0.69%
Min Revenue beat(4)-4.07%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.32%
PT rev (3m)-6.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.74%
EPS NY rev (1m)-0.28%
EPS NY rev (3m)-0.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.51 | ||
| Fwd PE | 26.63 | ||
| P/S | 3.43 | ||
| P/FCF | 20.67 | ||
| P/OCF | 12.94 | ||
| P/B | 4.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.73 |
EPS(TTM)4.35
EY2.74%
EPS(NY)5.96
Fwd EY3.75%
FCF(TTM)7.68
FCFY4.84%
OCF(TTM)12.27
OCFY7.73%
SpS46.31
BVpS35.5
TBVpS-35.06
PEG (NY)1.62
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.04% | ||
| ROE | 3.92% | ||
| ROCE | 5.11% | ||
| ROIC | 3.8% | ||
| ROICexc | 4.21% | ||
| ROICexgc | 13.6% | ||
| OM | 12.48% | ||
| PM (TTM) | 3% | ||
| GM | 45.76% | ||
| FCFM | 16.59% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexcg growth 3Y-35.26%
ROICexcg growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.54 | ||
| Debt/FCF | 8.09 | ||
| Debt/EBITDA | 4.76 | ||
| Cap/Depr | 80.56% | ||
| Cap/Sales | 9.91% | ||
| Interest Coverage | 2.25 | ||
| Cash Conversion | 106.92% | ||
| Profit Quality | 552.64% | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 0.88 | ||
| Altman-Z | 1.9 |
F-Score7
WACC7.32%
ROIC/WACC0.52
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)33.21%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%7.02%
EPS Next Y22.55%
EPS Next 2Y20.62%
EPS Next 3Y22.38%
EPS Next 5Y19.58%
Revenue 1Y (TTM)3.8%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%2.74%
Revenue Next Year5.4%
Revenue Next 2Y7.24%
Revenue Next 3Y8.62%
Revenue Next 5Y8.96%
EBIT growth 1Y1.03%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year103.14%
EBIT Next 3Y38.58%
EBIT Next 5Y26.7%
FCF growth 1Y187.94%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y14.51%
OCF growth 3Y4.07%
OCF growth 5Y20.79%